Literature DB >> 1877743

Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics.

H Rommelspacher1, L G Schmidt, T May.   

Abstract

Based on the hypothesis that condensation products of neurotransmitters with aldehydes are involved in the pathogenesis of alcoholism, aromatic beta-carbolines (norharman and harman) were measured in the blood plasma of alcoholics and nonalcoholics. The identity of the extracted compounds was confirmed by various elution conditions of the high performance liquid chromatography (HPLC), newly developed radioreceptor assays, and the mass spectrum of norharman. The levels of norharman and harman in nonalcoholics were unchanged after a load with ethanol (1 g/kg body weight). The norharman levels of the alcoholics were significantly higher than that of the nonalcoholic controls (99.5 +/- 26.6 pg/ml vs. 26.9 +/- 10.7 pg/ml; p less than 0.001) and did not change significantly during a 3-week detoxication period. In the subgroup of alcoholics with delirium or hallucinosis, a slight increase of norharman during detoxication could be detected while in alcoholics with vegetative withdrawal symptoms norharman levels dropped slightly over time (p = 0.07). No difference was found with respect to harman between nonalcoholics and alcoholics. These results suggest disturbed regulatory processes in the formation and/or metabolism of norharman in alcoholics. Further investigations are needed to reveal a possible marker function of norharman in alcoholic patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1877743     DOI: 10.1111/j.1530-0277.1991.tb00559.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  21 in total

1.  [Alcohol-induced psychotic disorder--a diagnostic entity of its own?].

Authors:  M Soyka
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

Review 2.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

3.  Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models.

Authors:  Mrittika Chattopadhyay; Anindya Roy Chowdhury; Ting Feng; Charles-Antoine Assenmacher; Enrico Radaelli; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2019-05-20       Impact factor: 5.157

4.  Blood harmane concentrations and dietary protein consumption in essential tremor.

Authors:  E D Louis; W Zheng; L Applegate; L Shi; P Factor-Litvak
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

5.  Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls.

Authors:  Elan D Louis; Wendy Jiang; Marina Gerbin; Mary M Mullaney; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-08-11       Impact factor: 4.294

6.  Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.

Authors:  T May; A Greube; S Strauss; D Heineke; J Lehmann; H Rommelspacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

7.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in dystonia cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Monika Michalec; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2014-06-23       Impact factor: 4.294

8.  [3H]norharman ([3H]beta-carboline) binds reversibly and with high affinity to a specific binding site in rat liver.

Authors:  A Greube; H Rommelspacher
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

9.  Elevation of blood beta-carboline alkaloids in essential tremor.

Authors:  E D Louis; W Zheng; E C Jurewicz; D Watner; J Chen; P Factor-Litvak; M Parides
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

10.  Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor.

Authors:  Elan D Louis; Eileen Rios; Kathryn M Pellegrino; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2008-03-18       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.